SEC Form 4 · accession 0001136261-17-000150
PERNIX THERAPEUTICS HOLDINGS, INC. · PTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John A Sedor
Officer — Board Chairman and CEO · Director
Period of report
Jul 27, 2017
Accepted (ET)
Jul 31, 2017 · 4:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001024126
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jul 27, 2017 | F | 13,293 | $3.15 | D | 117,807 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the insider's exercise of his withholding right following the vesting of restricted share units.
- F2Consists of (x) 30,407 shares of common stock and (y) the unvested amount of previously-awarded restricted share units that vest in two equal installments of 43,700 shares, with the next installment vesting on July 26, 2018 and the final installment vesting on July 26, 2019.